FDA PFDD – Kendall Marcus, MD
Opening remarks from Kendall Marcus, MD.
FDA PFDD – Theresa Mullen, PhD
Theresa Mullen, PhD provides us with an overview of FDA PFDD Initiative.
FDA PFDD – Brenda Carr, MD
Brenda Carr, MD gives a scientific and medical overview of vitiligo.
FDA PFDD – Health Affects and Daily Impact – Topic 1
Five brave individuals share their experience with living with vitiligo and how it has impacted their health and daily life.
FDA PFDD – Discussion – Topic 1
Individuals share their stories on discussion topic #1 (Health Affects & Daily Impact) and the FDA takes live phone calls.
FDA PFDD – Current Approaches to Treatment – Topic 2
Individuals share their stories on topic # 2 (Current Approaches to Treatment) and the FDA takes live phone calls.
FDA PFDD – Discussion – Topic 2
Large-Group Facilitated Discussion Session For Topic #2: Current Approaches to Treatment
FDA PFDD – Closing Remarks
Closing remarks from Kendall Marcus, MD